Regeneron falls after Q1 miss; announces $3B share buybacks [Seeking Alpha]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Seeking Alpha
In Q1, REGN's topline contracted to $3.2B, indicating a ~1% YoY drop from the prior year quarter when sales from its COVID-19 antibody therapy Ronapreve, marketed with Roche ( OTCQX:RHHBY ), boosted its revenue. Sales excluding Ronapreve grew ~7% YoY, while its asthma therapy Dupixent, marketed with Sanofi ( SNY ), added $3.1B in net product sales globally, indicating ~24% YoY growth. "The Regeneron team has already made substantial progress this year, delivering our approved medicines to more patients around the globe, advancing our pipeline consisting of dozens of clinical-stage programs, and relentlessly pursuing cutting-edge science," CEO Leonard Schleifer said. However, Eylea marketed with Bayer ( OTCPK:BAYZF ) brought $2.3B in net sales with a ~1% YoY drop as its U.S. net product sales fell ~2% YoY to $1.4B mainly due to market dynamics, which led to lower volumes and a net selling price. Meanwhile, REGN's non-GAAP net income per diluted share fell ~5% YoY to $9.55, fal
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game [Yahoo! Finance]Yahoo! Finance
- Type 1 Diabetes Market Size to Worth USD 24.36 Bn By 2031 [Yahoo! Finance]Yahoo! Finance
- Takeda's dengue vaccine obtains WHO prequalification [Yahoo! Finance]Yahoo! Finance
- Exploring Groupe LDLC Société Anonyme And Two More Top Dividend Stocks On Euronext Paris [Yahoo! Finance]Yahoo! Finance
- WHO approves second vaccine against the mosquito-borne disease dengue as outbreaks intensify [FOX News]FOX News
SNY
Sec Filings
- 5/2/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- SNY's page on the SEC website